These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 34598319)

  • 1. Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy.
    Filatova EV; Krylova NS; Vlasov IN; Maslova MS; Poteshkina NG; Slominsky PA; Shadrina MI
    Mol Genet Genomic Med; 2021 Nov; 9(11):e1808. PubMed ID: 34598319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of Fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a Russian nationwide screening program using NGS technology.
    Savostyanov K; Pushkov A; Zhanin I; Mazanova N; Trufanov S; Pakhomov A; Alexeeva A; Sladkov D; Asanov A; Fisenko A
    Orphanet J Rare Dis; 2022 May; 17(1):199. PubMed ID: 35578305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical exome sequencing unravels the diverse spectrum of genetic heterogeneity and genotype-phenotype correlations in hypertrophic cardiomyopathy.
    Harikrishnan S; Koshy L; Ganapathi S; Jeemon P; Ramya Das NK; Urulangodi M; Madhuma M; Vysakh Y; Subran A; Lakshmikanth LR
    Int J Cardiol; 2024 Sep; 411():132273. PubMed ID: 38880420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First identification of homozygous truncating CSRP3 variants in two unrelated cases with hypertrophic cardiomyopathy.
    Janin A; Bessière F; Chauveau S; Chevalier P; Millat G
    Gene; 2018 Nov; 676():110-116. PubMed ID: 30012424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy.
    de Marvao A; McGurk KA; Zheng SL; Thanaj M; Bai W; Duan J; Biffi C; Mazzarotto F; Statton B; Dawes TJW; Savioli N; Halliday BP; Xu X; Buchan RJ; Baksi AJ; Quinlan M; Tokarczuk P; Tayal U; Francis C; Whiffin N; Theotokis PI; Zhang X; Jang M; Berry A; Pantazis A; Barton PJR; Rueckert D; Prasad SK; Walsh R; Ho CY; Cook SA; Ware JS; O'Regan DP
    J Am Coll Cardiol; 2021 Sep; 78(11):1097-1110. PubMed ID: 34503678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Studies of Hypertrophic Cardiomyopathy in Singaporeans Identify Variants in
    Pua CJ; Tham N; Chin CWL; Walsh R; Khor CC; Toepfer CN; Repetti GG; Garfinkel AC; Ewoldt JF; Cloonan P; Chen CS; Lim SQ; Cai J; Loo LY; Kong SC; Chiang CWK; Whiffin N; de Marvao A; Lio PM; Hii AA; Yang CX; Le TT; Bylstra Y; Lim WK; Teo JX; Padilha K; Silva GV; Pan B; Govind R; Buchan RJ; Barton PJR; Tan P; Foo R; Yip JWL; Wong RCC; Chan WX; Pereira AC; Tang HC; Jamuar SS; Ware JS; Seidman JG; Seidman CE; Cook SA
    Circ Genom Precis Med; 2020 Oct; 13(5):424-434. PubMed ID: 32815737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic basis and outcome in a nationwide study of Finnish patients with hypertrophic cardiomyopathy.
    Jääskeläinen P; Vangipurapu J; Raivo J; Kuulasmaa T; Heliö T; Aalto-Setälä K; Kaartinen M; Ilveskoski E; Vanninen S; Hämäläinen L; Melin J; Kokkonen J; Nieminen MS; ; Laakso M; Kuusisto J
    ESC Heart Fail; 2019 Apr; 6(2):436-445. PubMed ID: 30775854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal-to-Noise Analysis Can Inform the Likelihood That Incidentally Identified Variants in Sarcomeric Genes Are Associated with Pediatric Cardiomyopathy.
    Kurzlechner LM; Jones EG; Berkman AM; Tadros HJ; Rosenfeld JA; Yang Y; Tunuguntla H; Allen HD; Kim JJ; Landstrom AP
    J Pers Med; 2022 Apr; 12(5):. PubMed ID: 35629155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic evaluation of cardiomyopathies in Qatar identifies enrichment of pathogenic sarcomere gene variants and possible founder disease mutations in the Arabs.
    Al-Shafai KN; Al-Hashemi M; Manickam C; Musa R; Selvaraj S; Syed N; Vempalli F; Ali M; Yacoub M; Estivill X
    Mol Genet Genomic Med; 2021 Jul; 9(7):e1709. PubMed ID: 34137518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribosomal protein S6 kinase beta-1 gene variants cause hypertrophic cardiomyopathy.
    Jain PK; Jayappa S; Sairam T; Mittal A; Paul S; Rao VJ; Chittora H; Kashyap DK; Palakodeti D; Thangaraj K; Shenthar J; Koranchery R; Rajendran R; Alireza H; Mohanan KS; Rathinavel A; Dhandapany PS
    J Med Genet; 2022 Oct; 59(10):984-992. PubMed ID: 34916228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder.
    Li L; Bainbridge MN; Tan Y; Willerson JT; Marian AJ
    Circ Res; 2017 Mar; 120(7):1084-1090. PubMed ID: 28223422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Testing in Patients with Hypertrophic Cardiomyopathy.
    Bonaventura J; Polakova E; Vejtasova V; Veselka J
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of
    Lopes LR; Futema M; Akhtar MM; Lorenzini M; Pittman A; Syrris P; Elliott PM
    Amyloid; 2019 Dec; 26(4):243-247. PubMed ID: 31554435
    [No Abstract]   [Full Text] [Related]  

  • 14. Coverage and diagnostic yield of Whole Exome Sequencing for the Evaluation of Cases with Dilated and Hypertrophic Cardiomyopathy.
    Mak TSH; Lee YK; Tang CS; Hai JSH; Ran X; Sham PC; Tse HF
    Sci Rep; 2018 Jul; 8(1):10846. PubMed ID: 30022097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-exome sequencing reveals a likely pathogenic LMNA variant causing hypertrophic cardiomyopathy.
    Mahdavi M; Mohsen-Pour N; Maleki M; Ghasemi S; Tabib A; Houshmand G; Naderi N; Masoumi T; Pouraliakbar H; Kalayinia S
    Lab Med; 2024 Jan; 55(1):62-70. PubMed ID: 37246508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rare and Common Genetic Variation Underlying the Risk of Hypertrophic Cardiomyopathy in a National Biobank.
    Biddinger KJ; Jurgens SJ; Maamari D; Gaziano L; Choi SH; Morrill VN; Halford JL; Khera AV; Lubitz SA; Ellinor PT; Aragam KG
    JAMA Cardiol; 2022 Jul; 7(7):715-722. PubMed ID: 35583889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deleterious Rare Desmosomal Variants Contribute to Hypertrophic Cardiomyopathy and Are Associated With Distinctive Clinical Features.
    Wu G; Liu J; Ruan J; Yu S; Wang L; Zhao S; Wang S; Kang L; Wang J; Song L
    Can J Cardiol; 2022 Jan; 38(1):41-48. PubMed ID: 34500006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertrophy Regression With N-Acetylcysteine in Hypertrophic Cardiomyopathy (HALT-HCM): A Randomized, Placebo-Controlled, Double-Blind Pilot Study.
    Marian AJ; Tan Y; Li L; Chang J; Syrris P; Hessabi M; Rahbar MH; Willerson JT; Cheong BY; Liu CY; Kleiman NS; Bluemke DA; Nagueh SF
    Circ Res; 2018 Apr; 122(8):1109-1118. PubMed ID: 29540445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole Genome Sequencing Improves Outcomes of Genetic Testing in Patients With Hypertrophic Cardiomyopathy.
    Bagnall RD; Ingles J; Dinger ME; Cowley MJ; Ross SB; Minoche AE; Lal S; Turner C; Colley A; Rajagopalan S; Berman Y; Ronan A; Fatkin D; Semsarian C
    J Am Coll Cardiol; 2018 Jul; 72(4):419-429. PubMed ID: 30025578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy.
    Tran Vu MT; Nguyen TV; Huynh NV; Nguyen Thai HT; Pham Nguyen V; Ho Huynh TD
    Circ J; 2019 Aug; 83(9):1908-1916. PubMed ID: 31308319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.